Abstract
Children living in Sub-Saharan Africa are vulnerable to developmental delay, particularly in the critical first five years due to various adverse exposures including disease and nutritional deficiencies. Anaemia and iron deficiency (ID) are highly prevalent in pregnant mothers and young children and are implicated in abnormal brain development. However, available evidence on the association between anaemia, ID and neurodevelopment in Sub-Saharan Africa is limited. Using data from the Entebbe Mother and Baby Study prospective birth cohort, we examined the effect of maternal and child haemoglobin (Hb) levels and child iron status on developmental scores in 933 and 530 pre-school Ugandan children respectively. Associations between Hb levels, iron status and developmental scores were assessed using regression analyses adjusting for potential confounders. Lower maternal and child Hb levels were associated with reduced psychomotor scores at 15 months, while only lower Hb levels in infancy were associated with reduced language scores. We found no evidence that anaemia or ID was associated with cognitive or motor scores at five years. This study emphasizes the importance of managing anaemia in pregnancy and infancy and highlights the need for further studies on the effects of anaemia and ID in children living in Sub-Saharan Africa.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by Wellcome Trust [Grant numbers 209640 to A.M.M., 110255 to S.H.A., 064693, 079110, 095778 to AME] and with core awards to the KEMRI-Wellcome Trust Research Programme (203077) and by the Medical Research Council [Grant number MR/M025454/1 to AA]. For the purpose of Open Access, the authors have applied a CC-BY public copyright license to any author accepted manuscript version arising from this submission. The funders had no role in the design and conduct of the study, manuscript preparation or interpretation of the findings.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Medical Research Council (MRC)/ Uganda Virus Research Institute Re-search Ethics Committee (reference numbers: GC/127 and GC/127/15/04/35), Uganda National Council for Science and Technology and the London School of Hygiene and Tropical Medicine Ethics Committee (reference number: 790).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Joint first authors
maggie.nampijja{at}gmail.com (M.N.)
Alison.Elliott{at}lshtm.ac.uk (A.M.E.)
AAbubakar{at}kemri-wellcome.org (A.A.)
Emily.Webb{at}lshtm.ac.uk (E.L.W.)
Data Availability
The data presented in this study are available on request from the Principal Investigator of the Entebbe Mother and Baby Study, Uganda. The data are not publicly available due to data privacy restrictions.
